VC firm Sequoia Capital has issued a statement on Twitter saying that it is “adopting a policy of full compliance with the (Vasan Healthcare) investigation and has responded to all government inquiries it has received till yesterday. This was in response to reports that the Enforcement Directorate (ED) raided the Bangalore office of Sequoia Capital to probe about Sequoia’s investments in Vasan Healthcare. 1/3: Yesterday's ED visit is part of the ongoing investigation into Vasan where Sequoia India is a minority investor along with others. — Sequoia_India (@Sequoia_India) April 19, 2016 The company’s press statement said that it came to know of a regulatory investigation into Vasan through an article in September 2015. At this time, VT Bharadwaj who served on the Vasan Healthcare board as Sequoia’s India nominee ‘demanded that Vasan conduct a thorough investigation into the allegations’, but resigned from Vasan’s board in November 2015. Sequoia Capital India said that it has met with ED officials and answered all their questions, in and outside their offices in the course of the investigation. Not related to Aircel-Maxis case The company added that the ED visit was only in connection with the Vasan case, and that it had no association with either Aircel or Maxis Communications. In the Aircel-Maxis case, the CBI alleged that C Sivasankaran was pressurised to sell his 74% stake in Aircel to Maxis Communications, a communication service provider in Malaysia. A timeline of the Aircel-Maxis case here. Quick Heal stake dilution: In February, Sequoia Capital said that…
